Ingeneron

Developer of cell-separation technology for regenerative medicine

placeHouston, Texas, United States calendar_todayFounded 2005 groups30 employees language ingeneron.com

Innovation

18 patent families (12 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing, Operations & transport; filing pace slowing. Cited 873 times.

YearFilings
20125
20134
20146
20155
20167
20178
20183
20192
20204
20212
20223
20231

Social engagement

Social engagement: 4.1K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record; lead investors include Sanford Health.

Investor typeCountShare
Accelerator & incubator150%
Other / undisclosed150%

Recent activity

4 Feb 2026
Milestone
cert
Coming soon